OWL THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 30 Jul 2025)
What this means for you
Not registered yet, but its 08 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98844292
- Mark type
- Stylized text
- Filed
- 08 Nov 2024
- Published for opposition
- 13 May 2025
- Attorney of record
- Jennifer Sheehan Anderson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Owl Therapeutics, LLC, San Antonio, TX, US
- Owl Therapeutics, LLC, San Antonio, TX, US
Prosecution history
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — SOU EXTENSION 1 GRANTED
- 30 Jul 2025 — SOU EXTENSION 1 FILED
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 May 2025 — PUBLISHED FOR OPPOSITION
- 07 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
- 11 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
- 11 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN
- 09 Apr 2025 — ASSIGNED TO EXAMINER
- 08 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED